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Porcine epidemic diarrhea virus (PEDV), a member of the Coronaviridae family has become
increasingly probelmatic in the pig farming industry. Currently, there are no effective,
globally applicable vaccines against PEDV. Here, we tested a recombinant PEDV vaccine
candidate based on the expression of the core neutralising epitope (COE) of PEDV
conjugated to polymeric immunoglobulin G scaffold (PIGS) in glycoengineered
Nicotiana benthamiana plants. The biological activity of COE-PIGS was demonstrated
by binding to C1q component of the complement system, as well as the surface of antigen-
presenting cells (APCs) in vitro. The recombinant COE-PIGS induced humoral and cellular
immune responses specific for PEDV after both systemic and mucosal vaccination.
Altogether, the data indicated that PEDV antigen fusion to poly-Fc could be a
promising vaccine platform against respiratory PEDV infection.
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INTRODUCTION
Pork is the most widely eaten meat in the world; approximately, 1.3 billion pigs are produced each
year worldwide. The intensification and globalization of the swine industry has contributed to the
emergence and global spread of pathogens of swine, driven in part by frequent movements of pigs,
feed, and pork products at local, national, and international scales (Drew, 2011). For example,
porcine epidemic diarrhea (PED) spread from China to the United States (discovered in 2013) and
thereafter to Canada and Mexico (in 2014) (Lee, 2015). Large-scale PED epidemics recurred through
the pork industry and within 1 year, the virus had impacted ∼50% of US breeding herds, resulting in
the deaths of at least seven million piglets (Ojkic et al., 2015; Goede and Morrison, 2016). Similarly,
African swine fever (ASF) emerged in Eastern Europe from sub-Saharan Africa in 2007 and recently
re-emerged in most of Asia including China, Philippines, Vietnam and East Timor in 2018–2019
(Blome et al., 2020). There are risks of the virus spreading also to other countries, as shown by its
recent 2019 introduction to China (the world’s largest producer of pigs) and spread to neighboring
countries such as North and South Korea. Cases in South Korea were speculated to have occurred by
pigs crossing the demilitarized zone which is a 4 km-wide strip of land that is a buffer zone between
North and South Korea. Despite extensive precautions following first recorded cases in North Korea
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in May 2019, South Korea reported its first case in September
2019 and has culled about 400,000 pigs after an outbreak began
late last year (https://www.thepigsite.com/news/2020/10/south-
korean-officials-cull-1-500-pigs-after-asf-outbreak). More than
six million pigs have been culled overall in Asia (https://www.
bbc.co.uk/news/world-asia-49916065). Finally, the potential
importance of livestock pathogens for human public health
was exemplified by the H1N1 “swine flu” pandemic in 2009,
which originated from influenza A viruses circulating in pig
populations (Smith et al., 2009). These examples highlight the
need to build a global picture of pathogens of swine to enhance
preparedness and understand patterns of emergence and spread.
Thus, a versatile and efficient vaccine platform for swine diseases
would be helpful to easily and quickly develop new vaccines
against unknown or new pathogens which show a similar
infection pathway.
Recently, PED caused by coronavirus infection has re-
emerged, resulting in a substantial economic burden in pig
industry. The first recorded case was in the United Kingdom
in 1971 (Antas and Wozniakowski, 2019) and it subsequently
spread to many European countries, followed by the current
epidemic in Asian countries. Increasing problem is due to an
appearance of new variants of PEDV with deletions/insertion,
and several mutations in S (spike) 1 region (Lee et al., 2010; Lee,
2015; Jang et al., 2019). The reason for partial protection against
PEDV with the current vaccine based on the CV777 strain could
be explained by several sequence analyses. Zhao X. et al. have
compared the sequences between their 55 isolated Chinese field
strains (during 2011–2015) and foreign reference strains from
GenBank. The S genes shared identity with CV777 (93.8–95.7%),
CHGD-01 (94.6.0–98.3%), M98 (93.3–95.4%), attenuated DR13
(93.3–95.6%), and 83P-5_100th-passaged (93.7–96.0%) and
shared nucleotide (deduced amino acid) homologies of
96.1–99.2% (95.1–99.5%) with United States/Missouri102/2013
(Zhao et al., 2017). New isolates from Korean PEDV epidemic
strain, PED-CUP-B2014, were close to PEDVs currently
circulating in many countries including the United States, and
are distinct from many current vaccine strains (Park et al., 2018).
We also compared the sequences of S protein between CV777 and
various strains provided by NCBI including Korean



















16–1,173 16–536 537–1,173 753–773 1,063–1,105
834–878
1,169–1,173 417–547
Belongs to the alphacoronaviruses spike protein family. The KxHxx motif seems to function as an ER retrieval signal. In contrast to sergoroups 2 and 3,
glycoprotein from seogroup 1 is not cleaved into S and S2. Homotrimer. During virus morpphogenesis, found in a complex with M and HE proteins.
Interacts with host ANPEP. Note: Accumulates in the endoplasmic reticulum-Golgi intermediate compartment, where it participates in virus particle
assembly.
AAK38656.1 1,383 - 231–733 741–1,344 CV77, Pensaert and De Bouck
(1978)
A0A5B8YRH6 1,386 9.2% identity
(97.0% similar)
234–736 744–1,385 958–978 1,039–1,083
1,275–1,317
1,328–1,347 1,382–1,386 100% identity to
AAk3865631 in Uniprot Blast
AAM19716.1 1,386 92.5% identity
(97.0% similar)
234–736 744–1,347 Korean isolate; Kang et al.
(2005)
Q8QQ98 1,386 92.5% identity
(97.0% similar)
234–736 744–1,385 958–978 1,039–1,083
1,275–1,317
1,328–1,347 1,382–1,386 100% identity to
AAM19716.1 in Uniprot Blast
AGN293201 1,382 95.9% identity
(98.4% similar)
230–732 740–1,343 a new Porcineepidemic
diarrhea virus isolated of
China; Chen et al. (2012)
R9TI84 1,382 95.9% identity
(98.4% similar)
230–732 740–1,381 954–974 1,035–1,079
1,271–1,313
1,324–1,343 1,378–1,382 100% identity to
AGN29320.1 in Uniprot Blast
AST13221.1 1,380 97.8% identity
(99.3% similar)
235–737 745–1,348 85–7 mutant strain 1; Sun
et al. (2017)
A0A288Y8U4 1,380 98.1% identity
(99.3% similar)
235–737 745–1,378 959–979 1,040–1,084
1,276–1,318
1,329–1,348 100% identity to AST13221.1
in Uniprot Blast
ASU09581.1 1,386 91.9% identity
(96.6% similar)
234–736 744–1,347 HUA–PED96 Vietnam; Do Hai
et al. (2016)
A0AU2UB55 1,386 91.9% identity
(96.6% similar)
234–736 744–1,385 958–978 1,039–1,083
1,275–1,317






PEDV YZ, China; Wang et.al.
(2019)
A0A5B8YRH6 1,386 92.7% identity
(97.0% similar)
234–736 744–1,385 958–978 1,039–1,083
1,275–1,317
1,328–1,347 1,382–1,386 100% identity to MK841495
in Uniprot Blast
*Spike (S) protein consists with two domains (S1 and S2) with transmembrane (TM). The residues corresponding to each protein positions were represented in the table. Homology (%) is
compared to corona-like agent (CV777) as the causative pathogan, which was partially fulfilled Koch’s postulates and described by Belgium scientists at the Ghent University in 1978. The
Annotation and conditions in the UniRule (UR000865645) are derived from the following entries; P15423 (SPIKE_CVH22).
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(AAM19716.1), Chinese (AGN29320.1) and Vietnamese
(ASU09581.1) isolates and the homology was 94, 95.9, 92.1
and 91.9%, respectively (Table 1).
Over the past several years, platform technologies have been
developed that could make it possible for multiple vaccines to be
rapidly produced from a single system. Here we suggest
molecularly engineered adjuvant, named PIGS (Polymeric
Immunoglobulin Scaffold), which we demonstrated previously
to have an excellent in vitro, in vivo and ex vivo adjuvantic
properties (Kim et al., 2017b; Kim et al., 2018; Webster et al.,
2018). Thus, the vaccine comprises the antigen of choice
genetically linked to the poly-Fc domain of modified IgG
containing IgM-polymerisation C-terminal sequence, enabling
its polymerization similar to pentameric IgM. This is the basis of
its enhanced binding to complement and Fc gamma
immunoglobulin receptors. We tested this concept for
induction of systemic immunity against dengue infection in
mice (Kim et al., 2018). For a swine PEDV vaccine, PIGS
fused to PEDV antigen were tested by systemic and mucosal
administration. Mucosal (oral) immunization would be highly
desirable against the respiratory and enteric diseases caused by
complex bacterial and viral agents, as the induced responses could
potentially stop the infection before it can spread.
In this study, COE epitope antigen of the S1 protein of PEDV,
which is responsible for inducing neutralizing antibodies (Chang
et al., 2002; Chang et al., 2019; Ho et al., 2020; Sun et al., 2008),
was used to test the poly-Fc based vaccine against swine infection.
The COE and PIGS fusion protein were transiently expressed in
Nicotiana benthamiana plants and both systemic and oral
immunogenicity were analyzed in the mouse model.
MATERIALS AND METHODS
Gene Construction for Plant Expression
Vector
The core neutralizing epitope (COE) composed of 139 amino acid
(aa) length (aa position 499 to 637 of PEDV strain CV777 S gene;
UniProtKB-Q91AV1) was selected to develop PEDV vaccine and
synthesized with the plant codon optimization sequences. To
verify enhanced immunogenicity, an antigen delivery molecule, a
mouse IgG2a Fc based polymeric IgG scaffold (mPIGS) has been
fused to COE, which had demonstrated an increased antigen
specific antibody response and self-adjuvancity in our previous
dengue vaccine study (Kim et al., 2017b). The mPIGS gene
fragment was cloned into pGEM T-easy vector (Promega,
United States) by PCR amplification method using the
plasmid pMPIGS as the DNA template, with gene-specific
primers 5′-gcggtaccGCTTCATCTACAAAA-3′ (forward) and
5′-gc gagctcTTAGTAGCAAGTGCC-3′ (reverse). The PCR
conditions were as follows: 30 cycles of PCR amplification
(DNA strand denaturation at 94°C for 30 s, annealing at 58°C
for 30 s, and complementary strand synthesis at 72°C for 40 s) and
a final extension at 72°C for 10 min. The PCR product was
confirmed by DNA sequence analysis (COSMO Genetech,
South Korea). The gene encoding mPIGS was then fused with
COE using KpnI and SacI restriction enzyme sites in the
intermediate vector. To construct plant expression vector, the
fusion gene (COE-mPIGS, 1,203 kb) was PCR amplified with
forward and reverse primers (5′-TTTTGGTCTCAAGGTGCT
TCATCTACAAAA-3′; 5′- TTTTGGTCTCAAAGCTTAGTA
GCAAGTGCC-3′, respectively) and then cloned into
MagnIcon® transient expression vector, pICH31070 (kindly,
provided from Y Gleba, Icon Genetics, Germany). The
recombinant plasmid was designated pMYK-T10 and
transformed into Agrobacterium strain GV3010 using
electroporation method (Wise et al., 2006).
Agroinfiltration for a Transient Expression in
Plants
To increase binding avidity to low affinity Fcɤ receptors and
CD16a in particular, COE-mPIGS construct was expressed in
delta-XF variant tobacco cells which produce only residual xylose
and fucose glycans (Kim et al., 2015; Strasser et al., 2008). The
ΔXT/FT N. benthamiana seeds (kindly, provided from Strasser
R., Austria) were germinated in the greenhouse under the
conditions of 16 h light/8 h dark cycle at 25 ± 0.5°C. For
transient expression of COE-mPIGS protein, pro-vector
expression system was employed and Agrobacterium cells
(strain GV3010) harboring pICH20155 (5′ pro-vector),
plasmid pMYK-T10 (3’ pro-vector) and pICH14011 (integrase
vector), respectively, were co-infiltrated into 6-weeks old
plantlets. All procedures were described in our previous report
(Huy and Kim, 2017). Also, LBA404 agrobacterium harboring
plasmid encoding J chain, which links together monomeric units
in secretory IgA (SIgA) or pentameric IgM in nature (Johansen
et al., 2000) was also co-infiltrated, to improvemultimerization by
forming a disulfide bridge with the mu-tail piece at the
C-terminal end of mPIGS (Yoo et al., 1999). Briefly, three
agrobacteria (described above) were grown in Luria-Bertani
broth (LB) medium containing 50 μg/L kanamycin and 100 μg/
L rifampicin for in 100 ml culture at 28°C for 2 days, respectively.
The bacterial cells were harvested by centrifugation at 6,000 × g
for 5 min and suspensed in 5 L of MES infiltration buffer (10 mM
MES, 10 mM MgSO4, pH 5.5, 200 µM Acetosyringone). The
bacterial suspension solution was adjusted to OD600 value 
0.3 and pre-incubated for 2 h at room temperature before
agroinfiltration. Vacuum-infiltration was applied to plants
immersed in MES infiltration buffer. The bacterial cells
penetrated into the leaves by slowly releasing the air pressure
after 2 min holding at vacuum 0.1 mPa. The infiltrated plants
were further grown in greenhouse under 16 h continuous light
per day, and their leaves were harvested at day 6 post infiltration
for subsequent experiments.
Protein Extraction and Purification
To extract COE-mPIGS protein, the infiltrated leaves were
homogenised by blender with double volumes of chilled PBS
buffer. The crude protein extracts were filtered through two layers
of Miracloth (Calbiochem) and centrifuged twice at 14,000 rpm
for 30 min in a Beckman centrifuge (AvantiTM J25,
United States). The recombinant COE-mPIGS protein in the
supernatant was detected by Western blot analysis prior to
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purification. The supernatant was filtered through 0.22 µm filter
before loading onto a protein A agarose affinity column (Sigma)
previously equilibrated with the binding buffer. The column was
washed with five volumes of washing buffer (20 mM sodium
phosphate, pH 7.0). The bound antibodies were eluted with
elution buffer (0.1 M glycine-HCl, pH 2.7) and pH
immediately neutralized by addition of 1 M Tris base (pH
unadjusted). The recombinant protein elution fractions were
concentrated by Amicon Ultra- Centrifugal Filter Unit
(Millipore, Billerica, MA) and dialyzed using Slide-A-Lyzer
Dialysis (Thermo Fisher Scientific) in PBS buffer before
quantification by optical density method, at 280 nm. Aliquots
of the protein were stored at −20°C for further experiments.
Immunoblot Analysis
An aliquot of protein extracts containing 40 µg of TSP, along with
prestained molecular weight markers, were separated by 8%
(non-boiled condition) or 10% (boiled condition) SDS-PAGE
(Bio-Rad, United States) at 120 V for 2 h in Tris-glycine buffer,
pH 8.3 (25 mM Tris, 250 mM glycine and 0.1% SDS). The
separated protein bands were transferred onto Hybond C
membrane (Amersham Pharmacia Biotech, Piscataway, NJ,
United States) in transfer buffer (50 mM Tris, 40 mM glycine,
and 20% methanol) using a mini-transblot apparatus (Bio-Rad,
United States) at 130 mA for 2 h. To prevent non-specific
antibody reactions, membrane was blocked with 10% non-fat
milk powder in TBST buffer (Tris-buffered saline with 0.05%
Tween 20) with gentle agitation on a rotary shaker at 20 rpm
overnight. For detection of mPIGS, the membrane was incubated
with anti-mouse heavy chain specific antibodies conjugated to
alkaline phosphatase (Sigma A3438, United States) diluted (1:
7,000) in TBST buffer containing 0.3% non-fat dry milk. For
detection of COE, mouse anti-COE antiserum (diluted 1:5,000)
was used. The membrane was then washed three times with TBST
buffer and incubated for 2 h with rabbit anti-mouse light chain
specific antibodies conjugated with alkaline phosphatase (Sigma
SAB3701215, United States), diluted (1:7,000) in TBST buffer.
The membranes was washed twice with TBST buffer and once
with TMN buffer (100 mM Tris, pH 9.5, 5 mM MgCl2, and
100 mM NaCl). The colour was developed using premixed
BCIP/NBT solution (Sigma, United States).
C1q Complement Binding Assay
The first step in activation of the classical complement pathway is
the binding of C1q protein to antibodies-antigen complexes. To
better define one of the biological functions of COE-mPIGS, we
compared the C1q binding activity of these immune complex-like
molecules, with monomeric mouse IgG serving as a negative
control, by ELISA. The plates were coated with 1 µg/well of
human complement C1q (Calbiochem) in 100 µl of coating buffer
(15 mM Na2CO3; 35 mM NaHCO3 pH 9.6) at 4°C for overnight.
After washing three times with PBST buffer (Phosphate buffered
saline containing 0.05% Tween-20, pH 7.4), the plates were
blocked with 300 µL/well of 1% BSA in PBS buffer for 2 hat
37°C. The COE-mPIGS purified protein (10 μg/ml) were 2-fold
serially diluted in PBS buffer containing 0.1% BSA and incubated
at 37°C for 2 h. The mouse IgG antibody (Sigma) was used as the
negative control. After washing three times with PBST buffer, the
plates were incubated with 100 µl of anti-mouse IgG conjugated
with alkaline phosphatase (1:7,000 dilution, Sigma A3562, St.
Louis, MO, United States) as the secondary antibody, for 2 hat
37°C. Finally, 100 µl of phosphatase substrates (Sigma, S0942) was
added per well for 15–20 min at room temperature and optical
density measured at 405 nm in SUNRISE (Tecan,
United Kingdom, CT) ELISA reader.
Fcγ Receptor Binding Assay
Binding of antibody-antigen complexes to Fc receptors activates
effector cells, triggering activities such as phagocytosis,
inflammatory mediators release, and antibody-dependent
cellular cytotoxicity (ADCC). Therefore, we tested the ability
of binding of COE-mPIGS to Fc receptors present on J774
macrophage cells (ATCC), by flow cytometry. J774 cells
(ATCC) were cultured in complete RPMI medium (2 mM L-
glutamine, 10% Fetal Bovine Serum (FBS) in 5% CO2 incubator at
37 °C. The cells growing at 80% confluency were detached with
dissociation buffer (Invitrogen), centrifuged at 1,000 rpm for
5 min and resuspend in binding buffer (PBS containing 3%
BSA and 0.05% of sodium azide). 100 μg/ml of COE-mPIGS
purified protein was added to 1 million cells in 100 μlcell
suspension and incubated on ice for 2 h. Nonspecific binding
was minimized by washing thrice with 3 ml of binding buffer.
Cells were then incubated with 7.5 µl of anti-mouse IgG-FITC
antiserum (the Binding Site) as the secondary antibody, for 1 h on
ice. After washing, cells were resuspended in 500 µl of binding
buffer and analyzed for green fluorescence on a Becton-
Dickinson flow cytometer. Ten thousand cells were counted,
and results expressed as the percentage of cells positive for
FITC staining. Secondary antibody alone and unstained cells
were used for background staining.
Systemic Injection of Mice
All animal work was performed according to the requirements
and guidelines of the Korean Animal Protection Act (APA) of
2008 by the Ministry of Agriculture, Food, and Rural Affairs, and
the Laboratory Animal Act (LAA) of 2009 by the Ministry of
Food and Drug Safety, Republic of Korea. The Five-week-old
female BALB/c mice were purchased from Dong Yang Oriental
Company (Korea) and randomly distributed into four groups for
two independent immunization experiments. Mice were allowed
at least 1 week to acclimate before start of vaccination. To test
antigen immunogenicity, subcutaneous (s.c.) injection at the
scruff of the neck under isoflurane anaesthesia was performed
three times, at 3 weeks intervals, as described in Figure 4A. The
mice were subcutaneously administered with 10 µg of bacterial
COE (LSP removed) or 10 µg CoE-mPIGS protein, with or
without 5 µg cholera toxin-CT (Sigma, C8052). Antigen
combined with a commercial CT (Sigma) adjuvant or just PBS
were used for comparison purposes. To analyze antigen-specific
antibody responses from the mice sera, the blood was collected at
weeks 3, 6, and 8 (end of the experiment) and sera prepared as
described in Jespersgaard et al. (Jespersgaard et al., 1999). At the
end of experiment, splenocytes were isolated to quantitate
numbers of IgG-secreting cells (SCs) by ELISPOT or to
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perform lymphocyte proliferation assays as described previously
(Kim et al., 2016).
Oral Immunization of Mice
To test for oral immunogenicity, dried plant leaf powder from
glyco-engineered uninfiltrated ΔXT/FT plants or agroinfiltrated
plants containing 100 μg of COE-mPIGS, was re-suspended in
1 ml PBS buffer and weekly fed to five mice in each group by
gavage needle (Figure 5A), for 6 weeks in total. The material
expressing COE-mPIGS was used with or without Saponin
Quillaja sp adjuvant (2.5 mg/mouse, Sigma, S4521) and
bacterial recombinant COE protein alone and PBS buffer were
used as control groups in the study. Mice were starved for 8 h
before oral gavage for improved retention of the administered
material. Blood and fecal samples were collected before
immunization and 3 days after feeding at weeks 4 and 5, as
previously described (Huy et al., 2016). Sera were recovered from
coagulated blood by centrifugation at 13,200 rpm for 10 min and
stored at −70 C, while fecal samples (approximately 200 mg) were
suspended in 1 ml of PBS buffer supplemented with 0.01%
sodium azide, to inhibit action of bacteria. The fecal extracts
were collected by centrifugation at 13,200 rpm for 25 min and
used for detection of sIgA antibody responses.
Detection of Antigen Specific Antibody
Responses
The ELISA was used to determine the specific serum antibody
responses in immunized mice. The ELISA plates (96-well) were
coated with 10 μg/μl of bacterial antigen (bCOE) in coating buffer
and incubated at 37 C overnight. The plates were then washed
thrice with PBST buffer (PBS buffer with 0.05% Tween-20) and
blocked with 300 µl/well of PBS buffer containing 1% BSA at
37 C, for 2 h. Subsequently, the sera (starting dilution 1:100) and
fecal extracts (starting dilution 1:4) were 2-fold serially diluted (in
PBS buffer containing 0.1% BSA), and following 2 h incubation at
37 C, washed thrice with PBST buffer. 100 µl per well of 1:7,000
diluted anti-mouse IgG (Sigma) or anti-mouse IgA (Sigma)
conjugated to alkaline phosphatase was then added and
incubated for further 2 h at 37°C, followed by washing thrice
with PBST buffer. For colour development, 100 µl/well of alkaline
phosphatase p-nitrophenyl phosphate substrate system (Sigma,
S0942-100 TAB) in 10% diethanolamine, 0.1% MgCl2, 0.02%
sodium azide, pH 9.8, was added and plates incubated in the dark
for 20 min, at room temperature. The optical density was
measured at 405 nm using the SUNRISE reader (Tecan,
United Kingdom), and endpoint titres were determined as
2xfold about background.
ELISPOT Analysis
The Enzyme-Linked ImmunoSpot assay (ELISpot) was conducted
to quantify antigen-specific antibody-secreting B cells (ASC). The
PVDFmembranes of ELISpot plate were activated by incubating in
35% ethanol for 10min at room temperature. The plate was
washed thrice with PBS buffer to remove residue ethanol, and
500 ng/well of bacterial antigen (bCOE) added, in PBS buffer at 4°C
overnight. Following washing, 200 µl of complete RPMI containing
10% FBS was added and plates incubated at 37°C, 5% CO2, for 1 h,
to prevent non-specific binding. Splenocytes were isolated from
mice 10 days after final immunization using Percoll density
gradients. Viable splenocytes were counted by trypan blue
method (Thermo Fisher Scientific). Cells were diluted in
complete RPMI medium to 1 × 106, 5 × 105, and 1 × 105 cells/
well and then cultured at 37 °C, 5% CO2 for 2 days. After removal
of unbound cells by washing, anti-mouse IgG alkaline phosphatase
(Sigma) was added and following 2 h incubation at 37°C, the cells
were washed three times as before. ASCwere visualized by addition
of BCIP/NBT phosphatase substrate (Sigma) and colour spots
counted under microscope and computer.
T-Cell Proliferation Assay
T-cell proliferation ability of splenocytes from immunized mice
was determined by the [3H] thymidine incorporation method.
Mononuclear cells (MNCs) were isolated from the spleens of
immunized mice at 10-days after the final immunization.
Splenocytes suspensions were filtered using 70-µm cell strainer
and separated by percoll 40–70% gradient. The cells were washed
three times with PBS buffer (Sigma-Aldrich) and re-suspended in
complete RPMI medium containing 10% FBS (FBS; Invitrogen),
1 M HEPES, 1 M sodium pyruvate, 2 mM mercaptoethanol,
100 IU/ml penicillin and 100 μg/ml streptomycin. The cells
were seeded in 96-well plates at 1 × 106, 5 × 105 and 1 × 105
in 100 µL of complete RPMI medium, and 10 µg of bCOE added
(or medium alone as the negative control). After 48 h incubation
at 37°C in incubator 5% CO2, cells were pulsed with 0.5 µCi of
[3H]-thymidine deoxyribose (TdR) (Amersham Life Science,
Buckinghamshire, United Kingdom) per well, for an additional
18 h. Using a 96-well cell harvester (Inotech, Dottikon,
Switzerland), the cells were collected and assessed for tritium
incorporation using a liquid scintillation counter (Packard
Instrument, Meriden, CT, United States). Stimulation indices
were calculated by dividing the tritium incorporation (counts per
minute) in cells treated with cognate antigens by the
incorporation in control cells treated with PBS.
Data Analysis
Representative data from at least two or multiple experiments are
expressed as the means of replicate tests ±SD. The statistically
significant differences were determined by one-way ANOVA,
followed by Tukey’s for group-to-group comparisons, with values
of p < 0.05 considered statistically significant. Statistical analysis
was performed using IPMS® SPSS® statistics package, version 22.
RESULTS
Gene Construction and Agro-Infiltration
A causative pathogen of PED, coronavirus-like agent (CV777)
was discovered by Belgium scientists in 1978 (Lee, 2015).
Although the current vaccine based on the CV777 strain
shows only partial protection, we took the epitope from this
strain primarily to test our vaccine platform as a proof-of-
concept, that immunogenicity can be enhanced by molecular
means. The neutralizing epitope COE sequence that corresponds
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to the 15 kDa portion of the S protein was genetically fused to
poly-Fc gene construct from mouse IgG (mPIGS) (Kim et al.,
2017b). Both antigen and mPIGS genes were synthesized with
high frequency of codon usage in plants. To produce recombinant
PIGS fusion protein, pro-vector which was developed by Icon
Genetics, was employed as the plant expression vector (Gleba
et al., 2005). The linear DNA of COE-mPIGS gene inserted into
Bsa I restriction enzyme site within 3′ pro-vector was used to
express the construct transiently in tobacco cells. Tobacco leaves
were agro-infiltrated by combining the expression vector with a 5’
pro-vector for apoplast targeting of protein in the cells, and the
vector for expression of integrase (Figure 1A). All through the
expression, LBA4404 agrobacterium harboring plasmid encoding
J chain, which links together monomeric units in secretory IgA
(SIgA) or pentameric IgM in nature (Yoo et al., 1999), was also
co-infiltrated, to improve multimerization by forming a disulfide
bridge with the mu-tail piece at the C-terminal end of mPIGS
(Davis and Shulman, 1989; Frutiger et al., 1992; Fazel et al., 1997).
The single chain of COE-mPIGS may be assembled as a
homodimer or multimers, like a natural IgM antibody, leading
to enhanced Fc-receptor mediated functions (Figure 1B). For
expression, ΔXT/FT glyco-engineered tobacco plants (Strasser
et al., 2008) were used to produce glycan-optimized COE-mPIGS.
Expression of COE-mPIGS in
N.benthamiana Leaves
For the protein assay, the tobacco leaves infiltrated with A.
tumefaciens harboring three pro-vector components, with or
without J chain construct, were extracted in PBS buffer and
analyzed. Immunoblot analysis was conducted to detect the COE
and mPIGS portions in protein extracts using anti-COE polyclonal
sera or anti-mouse IgG heavy chain specific antibodies, respectively.
Samples of 40 micrograms of protein were extracted at 2, 4, and
6 days post infiltration (dpi) and boiled before separating on SDS-
PAGE gel. Following transfer, immunoblot membranes were probed
by anti-IgG antibody under non-reducing conditions, showing
varying sizes of COE-mPIGS, ranging from approximately 50–53,
100 kDa and above 170 kDa, possibly representing the single chains
(S), homodimers (D) and polymers (P) (Figure 2A). There were
significantly more polymeric forms in samples from 6 dpi compared
to 2 or 4 dpi, and importantly, with co-expression with J chain
compared to without J chain (Figure 2A left two panels). It was not
possible to determine the exact molecular weight of the polymeric
fraction or its proportion in the preparation, but as Figure 2A
indicates, the inclusion of J chain markedly enhanced the proportion
of dimers and especially polymers, suggesting their higher efficiency
assembly, into likely pentamers of approximately 500 kDa, while in
the absence of J chain the polymers likely represent hexamers of
approximately 600 kDa. Under reducing conditions, COE-mPIGS
fusion protein was dissociated into a single chain with molecular
weight of approximately 53 kDa, as detected by anti-mouse IgG
antibody and anti-COE polyclonal sera (Figure 2A right two
panels). The single chain of COE-mPIGS calculated by
ProtParam tools (https://web.expasy.org/protparam/) is 44.3 kDa,
but that excludes 4 potential N-glycans. There was no cross-
reactivity in protein extracts from non-infiltrated ΔXT/FT N.
benthamiana plants used as a negative control. The recombinant
COE purified from bacteria (bCOE) and a commercial IgG antibody
were used as positive controls, yielding 15 and 55 kDa protein bands
FIGURE 1 | Vector construction for plant expression of COE-mPIGS and a schematic diagram of poly-Fc platform (A) the structure of S protein of PEDV and plant
expression vector: three vectors were used to produce COE-PIGS simultaneously. pMYKT10, 3′ pro-vector containing COE-mPIGS gene; pICH20155, 5′ pro-vector
containing apoplast signal peptide sequence; and pICH14011 vector for expression of the integrase. LB and RB, left border and right border of T-DNA; P-Act2,
Arabidopsis actin 2 promoter; P-hsp, Arabidopsis heat shock protein hsp 81.1 promoter; NOS, nos terminator; 3′NTR, 3′ nontranslated regions of TMV; MP,
movement protein; Apo, apoplast targeting pre-sequence; int, intron; AttP and AttB, recombination sites; NLS, nuclear localization signal; T, terminator. (B)
Homodimeric structure of COE-PIGS presenting biologically active sites. COE, antigen of PEDV; Fcγ, Fc gamma chain based onmouse IgG2a; µ tp, µ tail piece of human
IgM; PIGS, Polymeric IgG Scaffold. The process of polymerization from a single chain is shown in a lower diagram. Polymers bind to both high and low affinity Fc
receptors (FcγI, FcγII, and FcγIII) embedded in antigen presenting cell (APC) resulting in enhancement of the immune responses, while monomeric IgG binds to only high
affinity Fc receptor (FcγI). Polymers can be denatured into single chain under reducing conditions.
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under reducing conditions, respectively (Figure 2A right two
panels).
The amount of COE-mPIGS protein in the leaf tissues was
measured using quantitative sandwich ELISA (Figure 2B left).
Known amounts of IgG2a were used to generate the standard
curve. The expression level of COE-mPIGS was approximately
0.74% of total soluble protein (Figure 2B right). There was no
non-specific antibody binding in protein extracts from non-
infiltrated leaves used as a negative control.
Protein Purification
For protein purification, the complex COE-mPIGS with J chain
was transiently expressed in ΔXT/FT N. benthamiana for 6 days
and the leaves were collected. The recombinant COE-mPIGS
protein was purified from protein extracts using protein A/G
affinity chromatography method and the eluted fractions (E1-E3)
were then analyzed by SDS-PAGE. As shown in Figure 3A,
purification products were shown to be approximately 53 kDa
(single, S), 110 kDa (dimer, D) and above 170 kDa (polymers, P)
protein bands. The commercial BSA (Sigma) was used as protein
standard for molecular weight comparison.
Characterization of Functional COE-mPIGS
Protein
Antigen-antibody complex (immune complex)-mediated
activation of the complement system, and IgG Fc receptors
(FcɤRs) mediated uptake, are important defence mechanisms
mediated by innate and adaptive immune responses. Thus, the
recombinant COE-mPIGS were tested for binding to C1q
complement component and to Fc gamma receptor-bearing
antigen presenting cells (APCs). As shown in Figure 3B, the
COE-mPIGS bound to C1q in dose-dependent manner
confirming the presence of polymeric forms of COE-mPIGS.
Similarly, FcɤR targeting by COE-mPIGS revealed a significantly
increased level of binding in mouse J774 macrophages, compared
to secondary mouse IgG-FITC antibody only. In contrast, the
monomeric IgG used as an internal control showed much less
binding to both C1q and FcɤR (Figures 3B,C).
Systemic and Oral Immunogenicity of
COE-mPIGS
To test for systemic immune responses, mice were subcutaneously
immunized with bCOE or PBS buffer or COE-mPIGS with or
without adjuvant (bacterial CT), on three separate occasions
(Figure 4A). The serum IgG antibody immune responses were
analyzed after weeks 3 and 6 by ELISA. As shown in Figure 4B,
mice given only bacterial antigen bCOE showed low IgG antibody
response, while mice immunized with COE-mPIGS with or
without adjuvant showed high-levels of IgG. The endpoint
antibody titers were detected at approximately 1:51,200 and 1:
204,800 in groups immunized with COE-mPIGS alone and COE-
mPIGSwith bCT, respectively (Figure 4B). As expected, therewere
FIGURE 2 | Expression of COE-mPIGS protein in tobacco (A) Immunoblot analysis of COE-PIGS co-expressed without/with J chain: the protein extracts from
infiltrated and non-infiltrated leaf tissues were analyzed by probing with anti-mouse IgG gamma chain specific or anti-COE polyclonal antibodies under non-reducing and
reducing conditions. PC, commercial mouse IgG or COE recombinant protein produced in E. coli used as positive controls; NC, non-infiltrated protein extract used as the
negative control; lanes 2, 4, and 6, protein extracts from the harvested leaves at 2, 4, and 6 days post-infiltration (dpi). Molecular weight markers are shown on the
left. (B) Indirect ELISA probing by anti-mouse IgG gamma chain specific antibody. The level of expression (approximately 0.7% of total soluble protein) was estimated by
comparing to commercial IgG protein by ELISA.
Frontiers in Pharmacology | www.frontiersin.org April 2021 | Volume 12 | Article 6530647
Tien et al. Plant Based Vaccine for PEDV
no anti-COE IgG responses in mice which received PBS buffer
only, as the control. Furthermore, COE-mPIGS induced higher
frequency of antibody secreting B cells, compared to antigen alone
(Figure 4C, left), and this was further enhanced by the presence of
the CT adjuvant. Similarly, we observed stronger antigen-specific
T cell proliferation of splenocytes from mice immunized with
COE-mPIGS compared to antigen alone, and like for B cells, this
was further enhanced by the adjuvant (Figure 4C, right).
To test for oral immunogenicity, sera and fecal extracts were
obtained from mice immunized with PBS, bCOE, and COE-
mPIGS alone or COE-mPIGS with tor without he saponin
adjuvant, and analyzed for COE specific IgG and IgA
antibodies. Saponin was used in this case as it is generally
considered to be a good oral adjuvant (Cox et al., 1998; Lee
et al., 2015; Pickering et al., 2006; Rajput et al., 2007; Sjolander
and Cox, 1998; Sun et al., 2009). Both serum IgG and fecal IgA
against COE were detected in mice immunized with COE-mPIGS
alone and when combined with saponin, at 4 and 5 weeks
(Figure 5B). While endpoint titres were not determined for
fecal IgA, based on single dilution measurement and internal
ELISA normalization, they could be inferred to be significantly
lower that serum IgG, at an estimated 1:1,000–1:2,000.
Interestingly, COE-mPIGS with saponin induced only
marginally enhanced serum IgG and fecal IgA antibody
responses, but this was not statistically different to COE-
mPIGS alone. While this was surprising, similar results were
also reported in another study of the oral immunogenicity of the
tEDIII-Co1 dengue antigen expressed in rice calli (Kim and Kim,
2019), suggesting that in our hands at least, saponin did not exert
strong gut adjuvanticity. However, taken together, our data show
that COE-mPIGS alone could induce both systemic and mucosal
antigen specific immune responses, and that combining these
routes of delivery could be used to effectively immunize against a
gut pathogen like PEDV.
DISCUSSION
In this study, we demonstrated enhanced immunogenicity of an
antigen against PEDV by molecular engineering of adjuvanticity.
The neutralizing epitope derived from CV777 strain, COE, was
fused to the polymeric Fc scaffold of IgG, as a new and promising
vaccine platform for induction of both systemic and mucosal
immune responses via the oral route. Our choice of antigen was
the COE epitope containing sequence, which was demonstrated
recently to induce PEDV neutralizing antibodies in mice when
expressed in plants in native trimeric form (Ho et al., 2020).
However, we emphasize that our primary aim was to develop a
suitable vaccine platform against this and similar veterinary
pathogens, rather than a ready-made vaccine, as that would
require further modifications, including inclusion of other
portions of the S protein as well as different variants of the virus.
PEDV belongs to the family Coronaviridae, genus
Alphacoronavirus relating to transmissible gastroenteritis virus
or transmissible gastroenteritis coronavirus (TGEV). There is no
cross-protection between TGE and PEDV even though both are
Coronaviruses and show similar clinical signs. It only infects pigs
and does not relate to human diseases caused by beta-coronavirus
such as Severe Acute Respiratory Syndrome (SARS), Middle East
Respiratory Syndrome (MERS) and Severe acute respiratory
syndrome coronavirus 2 (SARS-CoV2 or COVID-19). PEDV
is one of the major causes of high morbidity and mortality in
piglets worldwide and currently, inactivated and live attenuated
vaccines have been extensively used, but with limited success
only. To compound this, the high frequency of recombination
events in coronaviruses may result in the generation of novel
viruses with high genetic diversity, which could invoke
unpredictable changes in virulence during infections (Zhao
et al., 2017; Ou et al., 2020). Thus, the emergence of highly
virulent strains and the recurrent outbreaks even in vaccinated
farms highlight the need for more effective vaccines. Recently,
Park et al., demonstrated that the newly isolated PEDV strain
conferred critical passive immune protection to pigs against
epidemic PEDV infection (Park et al., 2018). An alternative
form of immunization against PEDV might be a mucosal
vaccine, which could control the infection at the sites of
pathogen replication in porcine small intestinal villous
epithelial cells or enterocytes (Lee, 2015). Yuchen Li et al.
demonstrated that PEDV could cause typical diarrhea in
piglets through a nasal spray (Li et al., 2018). That provides
FIGURE 3 | Purification of protein and a functional characterization assay (A) Recombinant COE-mPIGS was purified from plant extracts using protein A/G affinity
chromatography methods. The proteins were separated by SDS-PAGE under non-reducing conditions and visualized by Coomassie brilliant blue staining. Lane BSA,
bovine serum albumin; lane E1-E3: fractions of eluted protein. Pre-stained protein molecular weight standards and polymers (P), homodimer (D), and single chain (S)
shown on the left and right sides of the figure. (B)C1q complement binding by ELISA shown as 2-fold serial dilutions of COE-mPIGS (5 μg/ml). The protein extracts
from wild-type plant were used as the negative control. (C) Fc gamma receptor binding in J774 cells by FACS analysis. The COE-mPIGS binding histogram was overlaid
to that obtained for mouse IgG2a antibody or secondary antibody alone, used as negative controls.
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evidence for possible airborne transmission and subsequent
gastrointestinal dissemination and is useful in facilitating
strategies for PEDV prevention.
Generally, the S protein of coronavirus consists of S1 and S2
domains which mediate attachment and membrane fusion,
respectively. The N-terminal region of the S protein, S1
domain (amino acid position 231-733 in CV777, NCBI assess
no. NP 598310.1; 234-736 in Korean isolate, 2005, NCBI assess
no. AAM19716.1; 235-737 in 85-7 mutant, NCBI assess no.
AST13221.1; 234-736 in HUA-PED96 Vietnam isolate, NCBI
assess no. ASU09581.1; 230-732 in Chinese isolate, 2013, NCBI
assess no. AGN29320.1), is important for recognizing the
Porcine aminopeptidase N (pAPN) receptor, which is
predominantly expressed on the surface of epithelial cells of
small intestine, and has been identified as the cellular receptor
for PEDV (Nam and Lee, 2010). The summary of S protein
features of PEDV published in NCBI and UniProt was included
in Table 1. Many of subunit vaccine candidates against
coronaviruses have been developed using S and S1 domain,
or host cell receptor binding domain such as ACE2 (aa 321-536,
NCBI assess no. MN908947, NC_045512, MN985325,
MN988669) against SARS or SARS-CoV2 (Chakraborti et al.,
2005; He et al., 2004; He et al., 2006; Ou et al., 2020). Thus,
vaccine strategy targeting to pAPN receptor binding domain
could be used to protect against PEDV even though S
glycoprotein of PEDV is not cleaved into S1 and S2, in
FIGURE 4 | Mouse immune responses induced by systemic injection (A) Schedule for immunization and sample collection. The BALB/c mice were randomly
distributed into four groups. Mice were subcutaneously injected with PBS only, or with 10 µg of the purified COE-mPIGS protein alone or with 5 µg of bacterial cholera
toxin (bCT) as adjuvant. The blood samples were collected at 3 and 6 weeks post-immunization. (B) Detection of COE-specific serum IgG. COE-mPIGS and COE-
mPIGS + bCT significantly enhanced IgG antibody responses after boosting, while COE and PBS induced only a low level or no response, respectively. The
endpoint antibody titers were detected at approximately 1:51,200 and 1:204,800 for COE-mPIGS alone and COE-mPIGS with bCT, respectively. The results were
shown as the mean of triplicate measurements ±SD of the 1:100 dilution (left panel), and serial 2-fold dilutions starting from 1:100 dilution (right panel). (C) Cellular
immune responses. Spot forming units after bacterial COE antigen stimulation in pooled (n  4) cultures were detected by ELISpot assay (left panel) and the results
shown as the mean values of the number of antibody-secreting cells from triplicate cultures. bCOE protein induced only low-frequency antibody-secreting cells, while
COE-mPIGS and COE-mPIGS adjuvanted with bCT induced high-levels of the antibody-secreting cells. T cell proliferation was assessed by [3H] thymidine incorporation
assay (right panel). Stimulation index was calculated by dividing the CMP (counts per minute) of Ag-stimulated cultures by CPM of control cultures from three separate
experiments. **p < 0.01; ****p < 0.0005, by Tukey’s test.
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contrast to beta- and gammacoronaviruses split by furin enzyme
located between the two domains (Ou et al., 2020). An
alternative antigen to induce neutralizing antibodies
suggested by Chang et al., is called S1D fragment (residues
636–789) in CV777 strain, located between S1 and S2 domain,
and consisting of two linear epitopes. Anti-S1D5 (residues
744–759) and S1D6 (residues 756–771) antibodies reacted
with the native S protein of PEDV. Furthermore, two core
epitopes on S1D5 (748YSNIGVCK755) and S1D6
(764LQDGQVKI771) were detected by Pepscan analysis in a
previous study (Sun et al., 2008). More recent studies,
however, identified several neutralizing monoclonal
antibodies all binding to the S2 domain of the spike protein
(Okda et al., 2017). In fact, in that study, the S2 specific
monoclonal antibodies were also more neutralizing than
those targeting the S1 domain. This is interesting as it may
suggest that the S2 domain should be included in the antigen
moiety of any new PEDV vaccine, though it is not clear if natural
infection also induces predominantly S2 targeted antibodies.
This is not uncommon for viruses as for example, there are
many strongly neutralizing antibodies against the domain three
of the dengue E glycoprotein (Crill and Roehrig, 2001; Shrestha
FIGURE 5 | Mouse immune responses induced by oral administration (A) Protocol for immunization and sampling (B) Detection of COE-specific serum IgG (top
two panels) and fecal IgA (bottom two panels) in pooled samples for each group (left panels) and the individual mice (right panels), in 1:100 diluted serum and 1:4
diluted fecal extracts. COE-mPIGS and COE-mPIGS + Saponin induced significant IgG and IgA antibody titres after boosting. Only background responses were
detected for COE and PBS. The results are shown as the mean of triplicate measurements ±SD. *p < 0.05, **p < 0.01 and ***p < 0.001, by Tukey’s test.
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et al., 2010) and yet, natural infection does not induce such
antibodies (Wahala et al., 2009; Williams et al., 2012).
In this study, we employed poly-Fc of IgG as an antigen delivery
platform, with enhanced avidity of binding to both high and low
affinity Fc gamma receptors (Kim et al., 2017b; Kim et al., 2018;
Webster et al., 2018). This is an improvement on IgM which
despite being polymeric (pentamer or hexamer naturally) displays
low binding affinity for its receptor (Vollmers and Brandlein,
2006), or monomeric IgG which binds to only high affinity Fc
gamma receptor. This feature of poly Fc fusion as a vaccine is
expected to increase the efficiency of antigen-presentation
compared to uptake of a single antigen by the immune cells, as
schematically shown in Figure 1B. Also, binding to complement
component (C1q) in an antigen-antibody immune complex
manner could further enhance the adjuvant effect by activating
complement cascade in vivo (Dempsey et al., 1996). In our previous
studies, those functions were demonstrated using antigens of
human diseases such as dengue (Kim et al., 2017b; Kim et al.,
2018) and tuberculosis (TB) (Webster et al., 2018). Although the
initial attempts at generating Fc fusions showed only partial success
(Mekhaiel et al., 2011), further modifications and improvements of
the original molecule suggested by Smith et al. (1995), as described
for our polymeric platform, have enabled the application of this
concept as an efficient vaccine delivery system.
Here we utilized the poly-Fc technology to develop a swine
PEDV vaccine platform through either systemic injection or
mucosal (oral) administration, which is relevant and potentially
applicable to many enteric or respiratory diseases, such as TGEV,
ASFV, Influenza A Virus in Swine (IAV-S), porcine reproductive
and respiratory syndrome (PRRSV) and foot-and-mouth (FMDV)
caused by Coronaviridae, Asfarviridae, Orthomyxoviridae,
Togaviridae and Picornaviridae virus, respectively. These
diseases are a significant economic burden in pork industry
worldwide, and in need of better control through vaccination.
Our results showed that both antigen-specific humoral antibody
and cellular responses could be induced by either subcutaneous
injection (Figure 4) or oral delivery (Figure 5) of COE-PIGS.
Furthermore, in our other experiments (data not shown), the
recombinant S1D fusion PIGS (S1D-PIGS) protein administrated
to mice intranasally induced robust anti-S1D IgG and IgA
antibodies in sera and bronchoalveolar lavage and a balanced
Th1/Th2 cellular responses in the spleen, thus further
strengthening the evidence for the utility of the mucosal route.
As a further proof of evidence for this, we previously demonstrated
that crude extracts containing antigens expressed in rice cells,
including fragment ApxII from Actinobacillus pleuropneumonia
and COE–Co1 fusion protein for PEDV, when given to mice by
intranasal or oral route, also elicited antigen-specific IgG and IgA
in spleen and Peyer’s patches (Huy et al., 2012; Kim et al., 2017a).
Likewise, transgenic rice whole cells expressing a dengue antigen
fused to cholera toxin B subunit (CTB) or enterotoxigenic
Escherichia coli Heat-Labile Toxin B Subunit, when delivered
orally, also induced systemic and mucosal immune responses
(Kim et al., 2010; Kim et al., 2016; Kim and Kim, 2019).
Finally, another PEDV antigen (S1D), when fused to CTB and
expressed in tobacco cells also induced serum IgG and fecal IgA
responses against both CTB and S1D, following oral immunization
(Huy et al., 2016). However, those mucosal responses were
induced when antigen was fused to CTB (well known as a
general/mucosal adjuvant) or Co1 ligand (M-cell target peptide
of epithelial cells), while a proof of oral immunogenicity by PIGS
fusion molecules alone has been demonstrated for the first time in
this study.
The limitation of our study is that polymerization of COE-
PIGS in plants cannot be controlled, although it can be
significantly enhanced by inclusion of the J chain. IgM can
form both hexamers and pentamers, with the latter being
facilitated by the J chain. We indirectly conclude but provide
no experimental evidence, that most of the generated COE-PIGS
may also be pentameric. Functionally though, both pentamers
and hexamers (and even dimers) would retain the capacity for
improved binding to the FC-gamma receptors and enhanced
antigen presentation. Another limitation of our study is that,
while our primary aim was to validate the immunogenicity of this
new vaccine platform, we were unable to perform virus antibody
neutralization assays, or the in vivo pathogenic challenge studies,
as the mouse is not a suitable model for PEDV. Likewise, we
cannot infer that the antigen dosing in mice would be replicated
in pigs, as these are much larger animals. However, unlike drug
treatments, vaccine scale up in different-sized hosts does not
follow the same principles, and the optimal dose for pigs would
have to be established experimentally.
Going forward, and to address the above limitations, we now
intend to test this vaccination concept in pigs (the target animal),
by replacing the mouse Poly-Fc with that from swine and
expressing it in plants. Further modifications will include
inclusion of additional portions of the S protein. While this
vaccine candidate can be expressed in one of the more
conventional expression systems, such as mammalian cells
(Kim et al., 2017b), we propose plants as this emerging
biotechnology has shown considerable promise, with several
plant-expressed pharmaceuticals in human clinical trials.
Success examples of this technology are illustrated by the
deployment of the ZMapp antibody during the 2014 Ebola
epidemic (Lyon et al., 2014) and the phase II clinical trial of a
quadrivalent seasonal influenza VLP vaccine by Medicago Inc.
(Pillet et al., 2019). In particular, animal vaccine development
may benefit the most from this technology, due to somewhat less
stringent GMP requirements and the associated costs of
production, with the attractive possibility of delivering the
vaccine in edible form, through feeding.
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